XM does not provide services to residents of the United States of America.

MS says 2025 turning point for EU chemicals, names Akzo as top pick



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-MS says 2025 turning point for EU chemicals, names Akzo as top pick</title></head><body>

** Current demand growth in European chemicals lacks near term catalysts, but is set to improve from 2025, supported by interest rates' cuts and lower gas prices, says Morgan Stanley

** MS analysts anticipate 2.7% supply growth on average over the next four years (vs 4.6% over the past four years),

** It adds that combined with higher demand, the growth should lead to higher profits, based on higher utilisation rates and improving margins

** As chemicals companies have faced weak profitability in 2024 and are expected to provide 2025 guidance below consensus, the broker prefers names with high cash generation supported by identifiable growth drivers

** MS ups Wacker WCHG.DE, Lanxness LXSG.DE and Arkema AKE.PA on improved profitability, as the German companies are expected to see recovery in their main segments while the French group should benefit from the lithium batteries (LFP) market share gains within the EV market

** The broker names Akzo Nobel AKZO.AS its top pick, as shares recovery couples with expected growth and the relative low risk profile of the coating business

** It cuts Air Liquide AIRP.PA and Syensqo SYENS.BR to 'underweight', as the latter lacks near term catalysts to balance negative net pricing and the French group is challenged by sluggish customer capex growth

** The Stoxx Europe 600 Chemicals Index .SX4P is down 0.9%, with Air Liquide at the bottom of the index, at -2.2%, while Lanxess leads the risers, at +4.4%



Table summarizing Morgan Stanley's recommandation changes on European chemicals companies



FROM

TO

Chemicals Industry

Cautious

In-Line

AKE.PA

EW

OW

LXSG.DE

UW

OW

WCHG.DE

EW

OW

AIRP.PA

EW

UW

SYENS.BR

EW

UW

BASFn.DE

NA

EW

ELK.OL

NA

EW









Reporting by Alban Kacher

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.